Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: rodneyh07 who wrote (46127)	5/17/2018 11:13:38 PM
From: erippetoe	Read Replies (1) \| Respond to of 63284

You’re lucky. I’ve not been able to margin IMMU at E*TRADE for so many years now I can’t remember...

To: rodneyh07 who wrote (46127)	5/18/2018 8:49:52 AM
From: li3511	2 Recommendations Recommended By ladyPI urslor Read Replies (1) \| Respond to of 63284

Okay ... keep your IMMU shares in the cash side of the account, rather than the margin side. That will prevent (or at least make it more difficult) for those shares to be loaned to shorts. Squeeze ‘m! I’ve had my IMMU shares in cash since they were below $5, and not marginable anyway. Even so, at Fidelity they increase the margin requirement for all drug companies (e.g., BMY, JNJ) because of the portfolio concentration in a single industry.